EV/EBITDA
-2.81
+0.17+5.70%
45 min ago
Summary
- As of March 12, 2025, MLYS EV/EBITDA is -2.81, with a rise of +0.17 (+5.70%) during the most recent trading day.
- Over the past year, MLYS EV/EBITDA has increased by +4.12 (+59.45%).
- MLYS EV/EBITDA is now -72.39% below its all-time high of -1.63.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.7% | -5.9% | -4.9% |
| 1 m1 month | -31.9% | +32.0% | +25.1% |
| 3 m3 months | +7.0% | +6.3% | +7.9% |
| 6 m6 months | +25.7% | +6.3% | +13.3% |
| ytdytd | -8.1% | +8.2% | +6.7% |
| 1 y1 year | +59.5% | -7.9% | +2.1% |
| 5 y5 years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -72.4% | -3.33 | +15.6% | |
| 3 m | 3-month | -1.63 | -72.4% | -3.41 | +17.6% |
| 6 m | 6-month | -1.63 | -72.4% | -3.97 | +29.2% |
| 1 y | 1-year | -1.63 | -72.4% | -7.71 | +63.5% |
| 3 y | 3-year | -1.63 | -72.4% | -22.06 | +87.3% |
| 5 y | 5-year | -1.63 | -72.4% | -22.06 | +87.3% |
| alltime | all time | -1.63 | -72.4% | -22.06 | +87.3% |
Mineralys Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.81(+8.1%) |
| Date | Value |
|---|---|
| 2024 | -2.60(-27.8%) |
| 2023 | -3.60 |
FAQ
- What is Mineralys Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mineralys Therapeutics?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics EV/EBITDA year-on-year change?
What is Mineralys Therapeutics EV/EBITDA?
The current EV/EBITDA of MLYS is -2.81
What is the all time high EV/EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high EV/EBITDA is -1.63
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics EV/EBITDA has changed by -0.21 (-8.08%) since the beginning of the year
What is Mineralys Therapeutics EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by +4.12 (+59.45%)